Tiff Advisory Services LLC Buys New Position in iShares Biotechnology ETF $IBB

Tiff Advisory Services LLC purchased a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 55,000 shares of the financial services provider’s stock, valued at approximately $7,940,000. iShares Biotechnology ETF makes up approximately 1.7% of Tiff Advisory Services LLC’s holdings, making the stock its 11th largest holding. Tiff Advisory Services LLC owned approximately 0.13% of iShares Biotechnology ETF at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in IBB. SG Americas Securities LLC boosted its stake in iShares Biotechnology ETF by 96.3% in the third quarter. SG Americas Securities LLC now owns 28,569 shares of the financial services provider’s stock worth $4,125,000 after buying an additional 14,016 shares in the last quarter. Florin Court Capital LLP bought a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $11,116,000. Viewpoint Capital Management LLC lifted its holdings in shares of iShares Biotechnology ETF by 1,532.1% in the 3rd quarter. Viewpoint Capital Management LLC now owns 12,730 shares of the financial services provider’s stock worth $1,838,000 after acquiring an additional 11,950 shares during the last quarter. Bronte Capital Management Pty Ltd. grew its holdings in shares of iShares Biotechnology ETF by 12.6% during the 2nd quarter. Bronte Capital Management Pty Ltd. now owns 295,346 shares of the financial services provider’s stock valued at $37,000 after purchasing an additional 32,947 shares during the last quarter. Finally, Employees Retirement System of Texas bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $25,049,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $172.57 on Friday. The firm has a fifty day simple moving average of $171.68 and a two-hundred day simple moving average of $157.24. iShares Biotechnology ETF has a twelve month low of $107.43 and a twelve month high of $179.64.

iShares Biotechnology ETF Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Tuesday, December 16th were paid a $0.1831 dividend. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. The ex-dividend date of this dividend was Tuesday, December 16th. This represents a $0.73 dividend on an annualized basis and a dividend yield of 0.4%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.